<unk>  is used for control of hyperglycemia in<unk> -responsive diabetes mellitus of stable, mild, non-ketosis prone, type 2 diabetes. It is used when diabetes cannot be controlled by proper dietary management and exercise or when insulin therapy is not appropriate. National Kidney Foundation (2012 Update) claims that<unk>  does not require dosage uptitration even in end stage kidney disease.
Gliclazide
Glibenclamide
Linaclotide
Liranaftate
Lobeglitazone
Miglitol
Linagliptin
Saxagliptin